DEL VECCHIO, SILVANA
 Distribuzione geografica
Continente #
NA - Nord America 331
AS - Asia 186
EU - Europa 27
Totale 544
Nazione #
US - Stati Uniti d'America 329
SG - Singapore 170
IT - Italia 13
FI - Finlandia 9
KR - Corea 9
CN - Cina 4
CA - Canada 2
DE - Germania 2
PT - Portogallo 2
TW - Taiwan 2
JP - Giappone 1
NL - Olanda 1
Totale 544
Città #
Santa Clara 298
Singapore 90
Helsinki 9
Seoul 9
Naples 8
Belleville 2
Guangzhou 2
Los Angeles 2
Porto 2
Springfield 2
Atena Lucana 1
Bari 1
Boardman 1
Boves 1
Falkenstein 1
Kaohsiung 1
Phoenix 1
Prineville 1
Reston 1
Tokyo 1
Totale 434
Nome #
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 14
IN VITRO AND IN VIVO CHARACTERIZATION OF INDIUM-111 AND TECHNETIUM-99M LABELED CCK-8 DERIVATIVES FOR CCK-B RECEPTOR IMAGING. 12
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 12
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 12
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease. 12
Molecular imaging of tumor microenvironment FOREWORD 11
PET/CT in cancer research: from preclinical to clinical applications 11
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 11
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma 11
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 10
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 10
Nuclear imaging of apoptosis in animal tumor models 10
Preclinical imaging for targeting cancer immune evasion 10
99mTc-MIBI in the evaluation of breast cancer biology 10
PET/CT in radiation oncology 10
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 9
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 9
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 9
Nuclear imaging in cancer theranostics 9
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 9
Evaluation of metabolic response with F-18-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors 9
Molecular imaging of drug resistance in cancer 9
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 8
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 8
Bone Scintigraphy and SPECT/CT in Bisphosphonate-Induced Osteonecrosis of the Jaw 8
A new and selective radiolabeled áVâ3 peptide antagonist as tracer in tumor diagnosis 8
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 8
PET/CT in cancer research: from preclinical to clinical applications 8
Bone Marrow uptake of 99mTc-MIBI in patients with multiple myeloma 8
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 8
Radiolabeling approaches for cholecystokinin B receptor imaging 8
Targeting avb3 integrin receptor by a new and selective peptide antagonist for tumour imaging and radionuclide therapy 8
Preclinical Imaging in Targeted Cancer Therapies 8
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 8
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma 8
Usefulness of [In-111-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease 8
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 8
Gefitinib, a selective, tyrosine kinase inhibitor increases 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells. 7
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 7
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 7
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 7
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives 7
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 7
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 7
Molecular imaging of tumor microenvironment: challenges and perspectives 7
Washout of 99mTc-Sestamibi in predicting response to chemoterapy in patients with multiple myeloma 7
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 7
Bone Scintigraphy and SPECT/CT in Bisphosphonate-Induced Osteonecrosis of the Jaw 7
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 7
Dynamic coupling of 99mtc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 7
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 7
Use of 99mTc-sestamibi scintigraphy in multiple myeloma. 7
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 6
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-X-L modulation of inositol trisphosphate receptor type 3 6
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 6
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 6
A new role for nuclear medicine in multiple myeloma 6
99mTc-MIBI in the evaluation of breast cancer biology 6
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 6
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 6
Inhibition of early (99m)Tc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma 6
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines 6
Technetium 99m sestamibi in multiple myeloma 6
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 6
Preclinical imaging in oncology: advances and perspectives 6
Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors 6
Poorly diifferentiated small cell neuroendocrinecarcinoma localized in three different endocrine glands: Response to chemoteraphy and octreotide LAR. 5
MIBI as prognostic factor in breast cancer. 5
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. 5
Totale 553
Categoria #
all - tutte 2.496
article - articoli 2.109
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 62
Totale 4.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202429 0 0 0 0 0 0 0 0 1 7 16 5
2024/2025524 4 5 78 47 302 25 48 15 0 0 0 0
Totale 553